Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression.
Hepatol Int. 2023 Dec;17(6):1444-1460. doi: 10.1007/s12072-023-10544-7. Epub 2023 May 19.
Hepatol Int. 2023.
PMID: 37204655
Association between sarcopenia-related markers and cholelithiasis: A prospective and Mendelian randomization study.
Ma P, Li R, Zeng L, Hong C, Li Y, Liang S, Zhu H, Cui H, Wang J, He J, Li Z, Xu J, Liu L, Xiao L.
Ma P, et al.
Environ Toxicol. 2024 Jun;39(6):3473-3480. doi: 10.1002/tox.24215. Epub 2024 Mar 7.
Environ Toxicol. 2024.
PMID: 38450827
Item in Clipboard
Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study.
Li QM, Sun QC, Jian Y, He JZ, Zhu HB, Hong C, Zeng L, Li RN, Wang JR, Li Y, Chen LY, Weng X, Liu L, Dong HZ, Xiao LS, Cui H.
Li QM, et al.
Discov Oncol. 2023 Jun 19;14(1):105. doi: 10.1007/s12672-023-00708-0.
Discov Oncol. 2023.
PMID: 37336826
Free PMC article.
Item in Clipboard
Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study.
Xiao L, Liao Y, Wang J, Li Q, Zhu H, Hong C, Li R, He J, Cui H, Dong H, Zeng L, Liu L.
Xiao L, et al.
Cancer Immunol Immunother. 2023 Jul;72(7):2299-2308. doi: 10.1007/s00262-023-03417-3. Epub 2023 Mar 8.
Cancer Immunol Immunother. 2023.
PMID: 36884079
Free PMC article.
Item in Clipboard
Cite
Cite